How Peritoneal Mesothelioma Treatment Decisions Are Made

Every treatment plan starts with a closer look at your diagnosis. Your specialist will review your biopsy results, imaging and overall health before recommending the next steps. For many people, that recommendation includes CRS plus HIPEC. Others may begin with chemotherapy, immunotherapy or another treatment based on their diagnosis and whether surgery is the best option.

Your care plan may continue to evolve as your treatment team gathers more information or evaluates how your cancer responds to therapy. Ask your mesothelioma specialist what’s guiding those decisions. That makes it easier to follow the conversation and feel prepared as you weigh your options.

CRS plus HIPEC

Purpose: Remove all visible cancer from the abdomen and treat microscopic disease left behind.

Combines cytoreductive surgery with heated chemotherapy delivered directly into the abdominal cavity during the same operation.

Offers the strongest long-term outcomes for eligible patients, typically those with epithelioid cell type and a manageable PCI score, and involves the longest hospital stay and recovery commitment of the four options.

Ask your specialist: Am I a candidate, and what does my PCI score mean for eligibility?

Systemic Therapy

Purpose: Treat cancer throughout the body using chemotherapy, immunotherapy or both delivered through the bloodstream.

Serves people who don’t qualify for CRS plus HIPEC and those whose disease progresses after surgery.

Runs on an outpatient cycle and can function as therapy before HIPEC to shrink tumor burden or after HIPEC to address residual disease.

Ask your specialist: Is systemic therapy a bridge to surgery, or is it the primary plan for my case?

Clinical Trials

Purpose: Test emerging treatments not yet part of standard care. Includes approaches such as pressurized intraperitoneal aerosol chemotherapy and immunotherapy combined with CRS plus HIPEC.

Fits into your timeline before HIPEC, during HIPEC or after HIPEC for maintenance and recurrence, and often requires travel to a center running the specific trial.

Ask your specialist: Are there open trials that match my diagnosis and where I am in mesothelioma treatments?

Supportive Care

Purpose: Manage symptoms and protect quality of life.

Serves people who aren’t CRS plus HIPEC or systemic therapy candidates, or who choose not to pursue curative-intent treatment, and also applies during curative-intent treatment, addressing pain, nutrition and other symptoms throughout.

Involves your care team, a Patient Advocate and, often, a palliative care specialist.

Ask your specialist: How can supportive care fit into my plan regardless of which treatment path I choose?

Whether your specialist recommends surgery, systemic therapy or another option, ask for the reasoning behind that recommendation. A clear answer makes it easier to weigh your choices and prepare for what comes next.

Questions to Ask Before You Consider HIPEC

Not everyone diagnosed with peritoneal mesothelioma is a candidate for CRS plus HIPEC. Your cell type, how far the cancer has spread within the abdomen and your overall health all help determine whether surgery is likely to provide the greatest benefit. If CRS plus HIPEC isn’t recommended, ask your specialist what factors influenced that decision and whether another treatment could make surgery an option later.

What cell type of peritoneal mesothelioma do I have, and how does it affect my HIPEC candidacy?

Peritoneal mesothelioma has 3 cell types: epithelioid, biphasic and sarcomatoid. Epithelioid responds best to CRS plus HIPEC and generally has the strongest long-term outcomes. Biphasic contains a mix of cell types, while sarcomatoid is more aggressive and often requires a different treatment approach.

Ask your specialist to explain your pathology report, how your cell type influences your treatment plan and whether another pathologist should review your biopsy if the results are unclear. That review directly shapes which options are realistic for you, so it’s worth getting a clear answer before you move forward.

What is my PCI score, and what does it mean for my treatment options?

The Peritoneal Cancer Index measures how much cancer is present throughout 13 areas of the abdomen. Specialists also may use the Peritoneal Surface Disease Severity Score, which combines your symptoms, PCI score and cell type to help guide treatment recommendations.

Ask your specialist to explain your scores, how they arrived at them and how they influenced your treatment recommendation. Those numbers can make it easier to compare recommendations if you seek a second opinion for your mesothelioma diagnosis.

Am I a candidate for CRS plus HIPEC today? If not, what would need to change?

Some people qualify for CRS plus HIPEC immediately, while others may benefit from chemotherapy before surgery or another treatment approach. In some cases, improving another health condition or reducing the amount of cancer in the abdomen can make surgery possible later.

Ask what factors are keeping you from surgery, whether those factors can change and what treatment your specialist recommends in the meantime. If surgery isn’t an option, ask about other treatments and available clinical trials.

Should I get a second opinion at a high-volume HIPEC center before I decide?

Peritoneal mesothelioma is rare, and relatively few hospitals perform CRS plus HIPEC regularly. A second opinion at a center with extensive experience treating this disease can confirm your diagnosis, review your treatment options and determine whether another approach is available.

Ask your doctor to send your pathology slides, imaging and treatment records before your appointment. A Patient Advocate can also help identify a treatment center based on your location, insurance and other needs.

A recommendation for or against CRS plus HIPEC should come with a clear explanation. Before moving forward, confirm you understand how your diagnosis influenced that recommendation, whether other treatment options are available and when a second opinion may be worthwhile.

500+ SPECIALISTS AVAILABLE
Get to the Right Mesothelioma Cancer Center, Faster

Connect with top-rated mesothelioma specialists at a cancer center near you, who will personalize treatment options based on your diagnosis.

Find Your Center

Evaluating Your HIPEC Surgeon and Treatment Center

Not all HIPEC centers or the surgeons who work there bring the same experience to your case. The team you choose affects your outcome, and asking your doctor direct questions about that experience is a normal part of the process, not an imposition.

How many CRS plus HIPEC procedures have you personally performed in the past year and over your career?

Surgeon case volume predicts outcomes for CRS plus HIPEC more reliably than almost any other factor. A general surgical oncologist may have performed only a handful of these operations, while a high-volume mesothelioma surgeon has performed dozens to hundreds.

Ask for both numbers: the past year and the career total. A confident surgeon answers with specifics and offers to refer you to a higher-volume colleague if that’s a better fit for your case.

How many peritoneal mesothelioma cases does this center treat per year?

Many HIPEC centers see high volume overall, but most of those cases involve ovarian or colorectal cancer rather than peritoneal mesothelioma. Peritoneal mesothelioma follows its own decision-making framework, so overall HIPEC volume doesn’t tell you much about a center’s experience with your specific disease.

Ask specifically for the center’s peritoneal mesothelioma case volume, including annual numbers and total experience. If the center can’t separate that number from its general HIPEC volume, consider a center that runs a named peritoneal mesothelioma program instead.

Is this an NCI-designated cancer center, and has my case gone to a peritoneal mesothelioma tumor board?

These two questions give you credibility signals you can check yourself. NCI designation means the center meets federal standards for cancer research and care, and a multidisciplinary tumor board means surgical oncology, medical oncology, radiation oncology, pathology and radiology have reviewed your diagnosis as a peritoneal mesothelioma case rather than a general HIPEC case.

A confident answer sounds specific, something like a plan to present your case at next week’s peritoneal tumor board. If your center has no plan to convene one, that’s a reason to seek a second opinion.

What is this center’s complete cytoreduction rate and perioperative safety data for CRS plus HIPEC?

Complete cytoreduction, known as CC-0, means no visible disease remains after surgery, and it’s the strongest predictor of survival for CRS plus HIPEC. Your center’s 30-day and 90-day mortality data show how safely the team performs the procedure.

Ask for the center’s published rates and, where possible, rates for patients who match your cell type, PCI range and age. A center confident in its results will share those numbers and explain how they compare to high-volume benchmarks, while vague or dismissive answers signal that a second opinion is worth pursuing.

Questions About Your Peritoneal Mesothelioma Treatment Plan

After your specialist recommends a mesothelioma treatment plan, ask how each step fits into your care. Knowing what happens before surgery, during treatment and afterward helps you prepare for what’s ahead and understand why each recommendation matters.

What happens during CRS plus HIPEC, and how long does the procedure take?

Cytoreductive surgery removes portions of the omentum and, in some cases, sections of the intestine, spleen or other affected tissue. HIPEC then circulates heated chemotherapy through the abdominal cavity for roughly 60 to 90 minutes during the same operation, and total operative time typically runs 8 to 14 hours.

Ask your surgeon to walk you through the surgery planned for your case, which organs it may involve and what that means for your recovery. A specific answer tailored to your case, rather than a generic overview, signals a surgeon who has reviewed your file closely.

Will I need chemotherapy or immunotherapy before or after surgery, and what is the sequencing?

Most people who pursue CRS plus HIPEC for peritoneal mesothelioma receive multimodal therapy: chemotherapy or immunotherapy before surgery, after surgery or both. The sequencing depends on your cell type, PCI score, response to systemic therapy and your center’s approach to treatment.

Ask your surgeon to explain the full sequence, the reasoning behind it and which medical oncologist manages each phase. Ask about clinical trials before you start standard treatment too, since some trials close their eligibility after certain prior mesothelioma treatments.

Every part of your treatment plan should serve a clear purpose. Before you move forward, confirm you understand why your specialist recommends each step and how your plan might change as treatment progresses.

Peritoneal Mesothelioma Surgery Recovery and Follow-Up

Recovery from CRS plus HIPEC demands real commitment from you and your caregiver. Most people spend 7 to 14 days in the hospital and then spend another 6 to 8 weeks recovering at home, and structured follow-up imaging continues for several years after surgery.

What does recovery look like, and how will pain, nutrition and ascites be managed?

Ask your care team for a realistic timeline that covers your expected time in the ICU, your hospital stay and when your nutrition transitions from IV to oral intake. Ask specifically about pain management throughout that process.

Ascites, or fluid buildup in the abdomen, occurs commonly after this procedure, so ask what monitoring or drainage looks like if it happens to you. Many people underestimate the recovery commitment, so ask about home support, caregiver hours, lifting restrictions and how often you’ll need follow-up appointments during the first 6 to 8 weeks.

How will my response to treatment be monitored, and what does long-term follow-up look like?

Standard follow-up after CRS plus HIPEC combines clinic visits, imaging and bloodwork on a tiered schedule, with appointments and scans happening more often during the first two years and less often after that. Ask your surgeon to lay out that imaging schedule and explain who orders and reviews each scan.

Ask what signs would trigger additional testing between scheduled visits. Also ask how your team would handle a recurrence, so you know what to expect if one occurs.

Recovery doesn’t end when you leave the hospital. Knowing what follow-up care involves and when to contact your team helps you prepare for the weeks and months ahead.

The Time Between Diagnosis and Meeting Dr.Sugarbaker

Exclusive Content

Tania Cole: The Time Between Diagnosis and Meeting Dr.Sugarbaker

Well, the truth is I wouldn’t have much time. That’s what the doctor said, in Fort Worth. He said, this is going fast. I mean, he needed treatment right away. And we were at the hospital. He was dismissed.

Then after that, and the next week, we had an appointment with to go and talk to Doctor. Sugarbaker and have another biopsy just to, you know, verify that he did have mesothelioma.

And after that, I think it was the next following week, he had the surgery. So it went pretty fast.

Getting Additional Support for Peritoneal Mesothelioma

Treatment often involves more than medical appointments. Patient advocates, financial resources, clinical trials and veterans’ benefits can all play a role before, during and after treatment, and asking about these services early makes it easier to manage travel, paperwork and other practical concerns throughout your care.

Working With a Patient Advocate

A Patient Advocate is one of the most valuable calls a person diagnosed with peritoneal mesothelioma can make after diagnosis. Advocates match patients to high-volume HIPEC centers by geography and insurance, and they coordinate the transfer of pathology slides and imaging to the specialty center you choose.

Advocates also connect families to financial and emotional support resources throughout treatment. Most people diagnosed with peritoneal mesothelioma need to travel to a specialized mesothelioma cancer center for care, since only about 20 U.S. centers perform CRS plus HIPEC at meaningful volume.

General Questions to Bring to Every Doctor Visit

People diagnosed with peritoneal mesothelioma see more than one specialist during treatment, and each visit calls for its own set of questions. Medical oncologists, radiologists, primary care doctors and palliative care specialists each manage a different piece of your care, so tailoring your questions to each visit helps you cover what matters most in that appointment.

Your Surgical Options Beyond HIPEC

CRS plus HIPEC is the standard surgical route for eligible people diagnosed with peritoneal mesothelioma, but it isn’t the only mesothelioma surgical option. Palliative debulking, exploratory laparoscopy for staging and other procedures for symptom management give people who don’t qualify for HIPEC today other approaches worth discussing with their care team.

Mesothelioma Clinical Trials and Emerging Treatments

Mesothelioma clinical trials are worth asking about at three points in your treatment: before HIPEC if you aren’t currently a surgical candidate, during HIPEC if a neoadjuvant immunotherapy or targeted therapy regimen is open to you, and after HIPEC for maintenance and recurrence protocols. Active research for peritoneal mesothelioma includes pressurized intraperitoneal aerosol chemotherapy and immunotherapy combined with CRS plus HIPEC.

Talk to your specialist about which trials, if any, apply to your diagnosis. Eligibility can change once you start standard treatment, so it’s worth asking early rather than after you’ve begun.

Learn what to ask before enrolling in a clinical trial

Resources for Veterans Diagnosed With Peritoneal Mesothelioma

Veterans exposed to asbestos in service, particularly those who served below deck in the Navy, worked in shipyards or handled insulation, boiler room or vehicle maintenance duties, may qualify for VA-covered CRS plus HIPEC and referral to a specialty center. VA disability claims and VA treatment benefits run as separate processes, though both are worth pursuing.

Before Your HIPEC Consult

  • Caregiver scheduled to attend the consult
  • Imaging (CT, PET, MRI) on disc or shared through a portal
  • Medical records forwarded to the specialty center
  • Pathology slides requested from the original biopsy lab
  • Patient Advocate contacted
  • Second-opinion center identified
  • Written list of the questions from this page

Support services can help long after your treatment plan is in place. Staying connected with your care team and asking about these resources makes treatment easier to navigate for you and your family.

FREE PERITONEAL MESOTHELIOMA GUIDE
Expert Guidance for Your Mesothelioma Journey

Get answers about treatment, top doctors, and financial support from the nation’s most trusted mesothelioma resource.

Get Your Free Guide

Frequently Asked Questions About Peritoneal Mesothelioma Treatment

What is HIPEC?

HIPEC circulates heated chemotherapy through the abdominal cavity for 60 to 90 minutes during cytoreductive surgery. The two procedures happen during the same operation, and together they form the standard curative-intent treatment for eligible people diagnosed with peritoneal mesothelioma.

Should I get a second opinion before HIPEC?

Yes, and for peritoneal mesothelioma, a second opinion at a high-volume HIPEC center counts as standard practice rather than an extra step. Most insurance plans cover the cost, and bringing your pathology slides, imaging and treatment notes to that appointment, along with a Patient Advocate’s help finding the right center, makes the process easier from the start.

What is the difference between CRS and HIPEC?

Cytoreductive surgery removes visible peritoneal mesothelioma from the abdominal lining, portions of affected organs and the omentum. HIPEC is the heated chemotherapy step that follows in the same operation, circulating through the abdominal cavity to treat the microscopic cells surgery alone can’t reach, and for peritoneal mesothelioma, the two procedures always happen together.

Are veterans eligible for VA-covered HIPEC?

Yes, veterans exposed to asbestos in service may qualify for VA-covered treatment, including referral to a high-volume HIPEC center. VA disability claims and VA treatment benefits run as separate processes, but both are worth pursuing.

Recommended Reading